Methylprednisolone Acetate Injection — FDA Drug Shortage

Current — Amneal Pharmaceuticals

The FDA lists a drug shortage record for Methylprednisolone Acetate Injection (injection) from Amneal Pharmaceuticals with status Current. The shortage was first posted on Dec 15, 2021.

Shortage details

Status
Current
Company
Amneal Pharmaceuticals
Package NDC
70121-1574-5
Dosage Form
Injection
Presentation
Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5)
Initial Posting
Dec 15, 2021

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.